Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Maurie Markman, MD
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Oncology Center at Providence Park
Mobile, Alabama, United States
- Hematology Associates, Ltd.
Phoenix, Arizona, United States
- Highlands Oncology Group, P.A.
Fayetteville, Arkansas, United States
- Cancer Center of Santa Barbara
Santa Barbara, California, United States
- Good Samaritan Medical Center
West Palm Beach, Florida, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Creighton University Cancer Center
Omaha, Nebraska, United States
- Jersey Shore Cancer Center
Neptune City, New Jersey, United States
- Women'S Health Center at Albany Medical Center
Albany, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Akron General Medical Center
Akron, Ohio, United States
- Oncology/hematology Care, Inc.
Cincinnati, Ohio, United States
- Cleveland Clinic Cancer Center
Cleveland, Ohio, United States
- Women'S Cancer Center of Central Pa, P.C.
Harrisburg, Pennsylvania, United States
- Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
- Brookview Research, Inc.
Nashville, Tennessee, United States
- Harrington Cancer Center
Amarillo, Texas, United States
- Rockwood Clinic P.S.
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 1997
- Primary completion
- —
- Completion
- —
- Last update posted
- 20 Apr 2011
- Registered enrollment
- 100
- Registry id
- NCT00003160
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.